Clinical Trials in Nîmes, GARD
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Pfizer600 enrolled235 locationsNCT06551324
Recruiting
Not Applicable
Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle254 enrolled7 locationsNCT06265558